#1 Source for Hair Loss and Propecia: Hair Loss Starters Guide - Propecia - Avodart - Rogaine - Nizoral
Special Hairloss Topics: Hair Transplant Advice - Hair Replacement Advice - Female Hair Loss
Revivogen
Ad: Revivogen
Regrowth.com

Hair Loss Study Abstract: Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.

Title
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Author
Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
Address
Laboratoire de Cancérologie Expérimentale, Faculté de Médecine Secteur Nord, Marseille, France.
Source
J Steroid Biochem Mol Biol, 55: 3-4, 1995 Dec, 375-83
Abstract
We compare testosterone (T) metabolism in primary cultures of epithelial cells and fibroblasts separated from benign prostate hypertrophy (BPH) and prostate cancer tissues. In all cultures, androstenedione (delta 4) formed by oxidation of T by 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) represented 80% of the metabolites recovered. The amounts of 5 alpha-dihydrotestosterone (DHT), formed by reduction of T by 5 alpha-reductase (5 alpha-R), were small: 5 and 2% (BPH) and 8 and 15% (adenocarcinoma) for epithelial cells and fibroblasts, respectively. Northern blot analysis of total RNA from epithelial cells (BPH or adenocarcinoma) attributed the reductive activity to the 5 alpha-reductase type 1 isozyme and oxidative activity to the 17 beta-HSD type 2. In cancer fibroblasts, only little 17 beta-HSD type 2 mRNA was detected. The 5 alpha-reductase inhibitors, 4-MA (17 beta-(N,N-diethyl)carbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one) and finasteride, inhibited DHT formation with a preferential action of 4-MA on epithelial cells (BPH or adenocarcinoma) and of finasteride on fibroblasts from adenocarcinoma. Neither inhibitor acted on delta 4 formation. On the other hand, the lipido-sterol extract of Serenoa repens (LSESr, Permixon) inhibited the formation of all the T metabolites studied [IC50 S = 40 and 200 micrograms/ml (BPH) and 90 and 70 micrograms/ml (adenocarcinoma) in epithelial cells and fibroblasts, respectively]. These results have important therapeutic implications when selecting appropriate treatment options for BPH.
Language of Publication
English
Unique Identifier
96132689
content2

Location:
Unknown

Location wrong? Click here
What's This?

Web
regrowth.com
Re-Mox 5% Minoxidil Combination Therapy
Ad: Re-Mox 5% Minoxidil Combination Therapy

More Info: Home | About Regrowth.com | How to Advertise | Privacy Policy | Advertising Policy | Contact Us
Site Map | Copyright © 2007 The Regrowth Network. All rights reserved. Legal Disclaimer

Other Cool Sites: Hair Loss Treatments - Body for Life Tracker - MedSpert

Propecia ® is a registered trademark of Merck. Avodart ® is a registered trademark of GlaxoSmithKline.
Rogaine ® is a registered trademark of Pfizer. Nizoral ® is a registered trademark of McNeil Consumer & Specialty Pharmaceuticals.